scholarly journals Erratum: Resolution of cystoid macular oedema after retinal detachment repair: is intravitreal triamcinolone useful?

Eye ◽  
2011 ◽  
Vol 25 (2) ◽  
pp. 259-259
Author(s):  
X Valldeperas ◽  
M R Romano ◽  
D Wong
Keyword(s):  
Retinal Detachment ◽  
Macular Oedema ◽  
Cystoid Macular Oedema ◽  
Intravitreal Triamcinolone

scholarly journals Intravitreal Bevacizumab and Triamcinolone for Treatment of Cystoid Macular Oedema Associated with Chronic Myeloid Leukaemia and Imatinib Therapy

2015 ◽  
Vol 2015 ◽  
pp. 1-3 ◽  
Author(s):  
Eric K. Newcott ◽  
Abdallah A. Ellabban ◽  
Shokufeh Tavassoli ◽  
Ahmed Sallam
Keyword(s):  
Chronic Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Macular Oedema ◽  
Intravitreal Bevacizumab ◽  
Imatinib Therapy ◽  
Cystoid Macular Oedema ◽  
Imatinib Treatment ◽  
Intravitreal Triamcinolone ◽  
Fellow Eye

Purpose.To evaluate the efficacy of intravitreal bevacizumab and triamcinolone in the treatment of cystoid macular oedema in a case with chronic myeloid leukaemia on imatinib treatment.Methods.We treated a 78-year-old man with bilateral cystoid macular oedema with intravitreal triamcinolone and subsequent bevacizumab in one eye and intravitreal bevacizumab, alone, in the fellow eye.Results.Serial intravitreal bevacizumab with and without triamcinolone treated cystoid macular oedema in both eyes and improved the vision.Conclusion.Intravitreal bevacizumab and triamcinolone could be viable options to treat cystoid macular oedema due to chronic myeloid leukaemia and imatinib therapy.

Safety of 6000 intravitreal dexamethasone implants

2019 ◽  
Vol 104 (1) ◽  
pp. 39-46 ◽  
Author(s):  
Bindu Rajesh ◽  
Javier Zarranz-Ventura ◽  
Adrian T Fung ◽  
Catharina Busch ◽  
Niroj Kumar Sahoo ◽  
...  
Keyword(s):  
Intraocular Pressure ◽  
Retinal Detachment ◽  
Macular Oedema ◽  
Real Life ◽  
Cystoid Macular Oedema ◽  
Dexamethasone Implant ◽  
Intravitreal Dexamethasone Implant ◽  
Intravitreal Dexamethasone ◽  
Phakic Eyes

PurposeTo evaluate the real-life safety profile of intravitreal dexamethasone implant injection for various retinal conditions.MethodsRetrospective multicenter analysis of intravitreal dexamethasone implant injections (700 µg) due to various retinal conditions including central retinal venous occlusion (1861 injections), diabetic macular oedema (3104 injections), post-surgical cystoid macular oedema (305 injections) and uveitis (381 injections). The eyes were evaluated mainly for the occurrence of adverse events such as glaucoma, cataract, retinal detachment and endophthalmitis along during the follow-up period.ResultsA total of 6015 injections in 2736 eyes of 1441 patients (mean age of 65.7±12.9 years) were in total analysed over an average period of 18 months (range 6 months to 102 months). A total of 576 eyes (32.5% of the phakic eyes) developed cataract requiring surgical intervention. However, visually insignificant cataract progression was observed in another 259 phakic eyes (14.6%) which did not require surgical removal. A total of 727 eyes (26.5%) experienced an intraocular pressure (IOP) rise of >25 mm Hg, with 155 eyes (5.67%) having a prior history of glaucoma and 572 eyes (20.9%) having new onset IOP rise. Overall, more than 90% of eyes with IOP rise were managed medically, and 0.5% eyes required filtering surgery. Endophthalmitis (0.07%), retinal detachment (0.03%) and vitreous haemorrhage (0.03%) were rare. There was no significant change in visual acuity (p=0.87) and central macular thickness (p=0.12) at the last follow-up.ConclusionThis is the largest real-life study assessing the safety of intravitreal dexamethasone implant injections in various retinal conditions. Cataract progression and intraocular pressure rise are the most common side effects, but are often rather easily manageable.

Full-thickness macular hole in a patient with diabetic cystoid macular oedema treated by intravitreal triamcinolone injections

2007 ◽  
Vol 85 (7) ◽  
pp. 795-798 ◽  
Author(s):  
Amélie Lecleire-Collet ◽  
Olivier Offret ◽  
David Gaucher ◽  
François Audren ◽  
Belkacem Haouchine ◽  
...  
Keyword(s):  
Macular Hole ◽  
Macular Oedema ◽  
Cystoid Macular Oedema ◽  
Full Thickness ◽  
Intravitreal Triamcinolone ◽  
Full Thickness Macular Hole

scholarly journals Pars plana vitrectomy with intravitreal triamcinolone: effect on uveitic cystoid macular oedema and treatment limitations

2006 ◽  
Vol 91 (3) ◽  
pp. 345-348 ◽  
Author(s):  
M. Gutfleisch ◽  
G. Spital ◽  
A. Mingels ◽  
D. Pauleikhoff ◽  
A. Lommatzsch ◽  
...  
Keyword(s):  
Macular Oedema ◽  
Pars Plana Vitrectomy ◽  
Cystoid Macular Oedema ◽  
Intravitreal Triamcinolone ◽  
Pars Plana

Intravitreal triamcinolone for persistent cystoid macular oedema in eyes with quiescent uveitis

2009 ◽  
Vol 37 (4) ◽  
pp. 389-396 ◽  
Author(s):  
Saskia M Maca ◽  
Claudette Abela-Formanek ◽  
Christopher G Kiss ◽  
Stefan G Sacu ◽  
Thomas Benesch ◽  
...  
Keyword(s):  
Macular Oedema ◽  
Cystoid Macular Oedema ◽  
Intravitreal Triamcinolone
Sign in / Sign up

Export Citation Format

Share Document